These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 5419966)
1. Number of lymph nodes examined and the prognosis of breast carcinoma. Fisher B; Slack NH Surg Gynecol Obstet; 1970 Jul; 131(1):79-88. PubMed ID: 5419966 [No Abstract] [Full Text] [Related]
2. A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome. Millis RR; Springall RJ; Hanby AM; Ryder K; Fentiman IS Cancer; 2002 Apr; 94(8):2307-9. PubMed ID: 12001132 [No Abstract] [Full Text] [Related]
3. Micrometastases in sentinel lymph nodes: few data make for hard decisions. Rowan K J Natl Cancer Inst; 2009 Oct; 101(20):1374-6. PubMed ID: 19797724 [No Abstract] [Full Text] [Related]
4. Primary carcinoma of the breast without axillary lymph node metastases. Fracchia AA; Rosen PP; Ashikari R Surg Gynecol Obstet; 1980 Sep; 151(3):375-8. PubMed ID: 7404307 [No Abstract] [Full Text] [Related]
5. Axillary recurrence of breast cancer following negative sentinel lymph node biopsy and axillary clearance. Cserni G Eur J Surg Oncol; 2000 Sep; 26(6):629. PubMed ID: 11034819 [No Abstract] [Full Text] [Related]
6. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825 [TBL] [Abstract][Full Text] [Related]
7. Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have prognostic significance? Salama JK; Heimann R; Lin F; Mehta N; Chmura SJ; Singh R; Kao J Cancer; 2005 Feb; 103(4):664-71. PubMed ID: 15641038 [TBL] [Abstract][Full Text] [Related]
8. The axillary lymph nodes in breast cancer. Seven years on. Steele RJ J R Coll Surg Edinb; 1983 Sep; 28(5):282-91. PubMed ID: 6358482 [No Abstract] [Full Text] [Related]
13. [Lymphogenic metastasis of breast carcinoma]. Schremmer CN; Kochem HG Z Lymphol; 1979 Jun; 3(1):5-8. PubMed ID: 539065 [No Abstract] [Full Text] [Related]
14. Lymph node staging surgery and breast cancer: potholes in the fast lane from more to less. Moffat FL J Surg Oncol; 2005 Feb; 89(2):53-60. PubMed ID: 15660377 [No Abstract] [Full Text] [Related]
18. Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer. Voogd AC; de Boer R; van der Sangen MJ; Roumen RM; Rutten HJ; Coebergh JW Eur J Surg Oncol; 2001 Apr; 27(3):250-5. PubMed ID: 11373100 [TBL] [Abstract][Full Text] [Related]
19. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma. Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808 [TBL] [Abstract][Full Text] [Related]
20. Predictors of non-sentinel lymph node metastasis in breast cancer patients. Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE; Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]